Recombinant Human CDKN2B protein

• Cat.No.: CDKN2B-32H
• Product Overview: Recombinant Human CDKN2B, was expressed in E. coli.

Specification

• Description: This gene lies adjacent to the tumor suppressor gene CDKN2A in a region that is frequently mutated and deleted in a wide variety of tumors. This gene encodes a cyclin-dependent kinase inhibitor, which forms a complex with CDK4 orCDK6, and prevents the activation of the CDK kinases, thus the encoded protein functions as a cell growth regulator that controls cell cycle G1 progression. The expression of this gene was found to be dramatically induced by TGF beta, which suggested its role in the TGF beta induced growth inhibition. Two alternatively spliced transcript variants of this gene, which encode distinct proteins, have been reported.
• Source: E.coli
• Species: Human
• Form: 20mM Tris.Cl, 50mM NaCl, 50% Glycerol, pH9.0.
• Molecular Mass: 14.7kDa
• Protein length: 138aa
• Applications: WB, ELISA, IP, antibody production, protein array
• Storage: Store at -80°C and avoid repeated freeze-thaw cycles

Gene Information

• Gene Name: CDKN2B cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) [ Homo sapiens ]
• Official Symbol: CDKN2B
• Synonyms: CDKN2B; CDK4I; INK4B; MTS2; P15; p15INK4b; TP15; MTS-2; p14-INK4b; p14_INK4B; p15-INK4b; p15_INK4B; CDK4B inhibitor
• Gene ID: 1030
• mRNA Refseq: NM_004936
• Protein Refseq: NP_004927
• MIM: 600431
• UniProt ID: P42772
• Chromosome Location: Cell Cycle, organism-specific biosystem; Cell Cycle, Mitotic, organism-specific biosystem; Cell cycle, organism-specific biosystem; Cell cycle, conserved biosystem; Cyclin D associated events in G1, organism-specific biosystem; G1 Phase, organism-specific biosystem; G1 to S cell cycle control, organism-specific biosystem
• Pathway: cyclin-dependent protein kinase inhibitor activity; cyclin-dependent protein kinase inhibitor activity; kinase activity; protein binding; protein kinase binding